Silvercrest Asset Management Group LLC lifted its position in Steris PLC (NYSE:STE) by 4.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 305,624 shares of the medical equipment provider’s stock after purchasing an additional 12,362 shares during the period. Silvercrest Asset Management Group LLC owned about 0.36% of Steris worth $28,534,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of STE. Captrust Financial Advisors acquired a new position in shares of Steris in the 4th quarter valued at $101,000. Meeder Asset Management Inc. lifted its stake in shares of Steris by 1,122.4% in the 4th quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock valued at $104,000 after purchasing an additional 1,100 shares during the period. YorkBridge Wealth Partners LLC acquired a new position in Steris during the fourth quarter worth $113,000. Hanson & Doremus Investment Management acquired a new position in Steris during the first quarter worth $140,000. Finally, Zions Bancorporation acquired a new position in Steris during the first quarter worth $200,000. Hedge funds and other institutional investors own 90.72% of the company’s stock.

In other news, VP Sudhir K. Pahwa sold 1,981 shares of the company’s stock in a transaction on Wednesday, April 18th. The shares were sold at an average price of $97.11, for a total transaction of $192,374.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Karen L. Burton sold 1,204 shares of the company’s stock in a transaction on Friday, May 11th. The stock was sold at an average price of $102.74, for a total transaction of $123,698.96. The disclosure for this sale can be found here. Insiders have sold 55,395 shares of company stock valued at $5,698,019 over the last 90 days. 2.38% of the stock is currently owned by company insiders.

Separately, Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $118.00 price objective for the company in a research report on Wednesday, June 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Steris currently has an average rating of “Buy” and a consensus target price of $87.80.

Steris opened at $106.06 on Wednesday, MarketBeat reports. The company has a quick ratio of 1.97, a current ratio of 2.48 and a debt-to-equity ratio of 0.41. The firm has a market cap of $9.04 billion, a price-to-earnings ratio of 25.56 and a beta of 1.13. Steris PLC has a fifty-two week low of $79.68 and a fifty-two week high of $107.62.

Steris (NYSE:STE) last posted its quarterly earnings data on Wednesday, May 9th. The medical equipment provider reported $1.24 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.02. The company had revenue of $716.00 million during the quarter, compared to analysts’ expectations of $703.37 million. Steris had a net margin of 11.10% and a return on equity of 11.55%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.11 earnings per share. equities research analysts predict that Steris PLC will post 4.71 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 28th. Shareholders of record on Friday, June 8th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Thursday, June 7th. Steris’s dividend payout ratio is presently 29.88%.

Steris Profile

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.

Want to see what other hedge funds are holding STE? Visit to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with's FREE daily email newsletter.